Cobio Diagnostics Overview
- Year Founded
-
2016
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$249K
- Investors
-
2
Cobio Diagnostics General Information
Description
Operator of a biotechnology company intended for rapid bacterial identification and antibiotic susceptibility tests. The company's technology utilizes a phage-based immunoassay to directly identify specific bacterial species and determine the effective course of antibiotic treatment and targeted alternative to traditional diagnostic techniques, enabling healthcare providers to make quicker and informed decisions about antibiotic use for patients with bacterial infections.
Contact Information
Website
www.cobio.coCorporate Office
- 12635 East Montview Boulevard
- Suite 219
- Aurora, CO 80045
- United States
Corporate Office
- 12635 East Montview Boulevard
- Suite 219
- Aurora, CO 80045
- United States
Cobio Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 16-Nov-2023 | $249K | Completed | Generating Revenue | ||
| 3. Accelerator/Incubator | 01-Jul-2021 | Completed | Generating Revenue | |||
| 2. Grant | 17-Sep-2020 | $251K | $275K | Completed | Startup | |
| 1. Angel (individual) | 20-Mar-2018 | $275K | $275K | Completed | Startup |
Cobio Diagnostics Patents
Cobio Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260219269-A1 | Kit for identifying antimicrobial agents and effective concentrations thereof | Pending | 08-Mar-2021 | ||
| AU-2022232903-A1 | Method and kit for identifying antimicrobial agents and effective concentrations thereof | Active | 08-Mar-2021 | ||
| CA-3211336-A1 | Method and kit for identifying antimicrobial agents and effective concentrations thereof | Pending | 08-Mar-2021 | ||
| EP-4305423-A1 | Method and kit for identifying antimicrobial agents and effective concentrations thereof | Pending | 08-Mar-2021 | ||
| EP-4305423-A4 | Method and kit for identifying antimicrobial agents and effective concentrations thereof | Pending | 08-Mar-2021 | G01N33/56916 |
Cobio Diagnostics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Advanced Industries Accelerator | Government | |||
| US National Science Foundation | Accelerator/Incubator | Minority |
Cobio Diagnostics FAQs
-
When was Cobio Diagnostics founded?
Cobio Diagnostics was founded in 2016.
-
Where is Cobio Diagnostics headquartered?
Cobio Diagnostics is headquartered in Aurora, CO.
-
What industry is Cobio Diagnostics in?
Cobio Diagnostics’s primary industry is Drug Discovery.
-
Is Cobio Diagnostics a private or public company?
Cobio Diagnostics is a Private company.
-
What is Cobio Diagnostics’s current revenue?
The current revenue for Cobio Diagnostics is .
-
How much funding has Cobio Diagnostics raised over time?
Cobio Diagnostics has raised $275K.
-
Who are Cobio Diagnostics’s investors?
Advanced Industries Accelerator and US National Science Foundation have invested in Cobio Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process